Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

The Eastern Ontario Health Unit is advising a new treatment is now available in the region to help protect infants from the ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

A new analysis from Imperial's human challenge study of COVID-19 has revealed subtle differences in the memory and cognition ...

AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted ... You are encouraged to report vaccine adverse events to the US Department of Health and Human Services. Visit www.vaers.hhs.gov to file a ...

Colorado's health department is working to get more information out to the public about circulating respiratory viruses. It’s ...

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

A 3D reconstruction of a mouse lung four days after infection with fluorescent Sendai virus reveals widespread virus presence (red) and active replication (green).

Respiratory virus infections in symptomatic and asymptomatic children upon hospital admission: new insights - Volume 4 Issue ...

The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...